Contact

ALS Worldwide welcomes any questions or comments you might have.  We provide free, personalized and confidential support services to anyone in the ALS community—whether you are a patient or a loved one, friend, health care professional or caregiver of someone diagnosed.

Get help now! Fill out the Online Profile Form or if you would prefer to talk with someone by email or phone first, please contact us at [email protected] or 1-608-663-0920.

For all other inquiries, please use the email form to the right and we will respond promptly to your request.Thank you.

ALS Worldwide
5808 Dawley Drive
Fitchburg, WI 53711‑7209

ALS Worldwide
May 15, 2017

ALS Worldwide Pioneered and Continues the Use of Neudexta

Printer Friendly

ALS Worldwide specializes in helping ALS patients relieve symptoms by using and embracing drugs that improve quality of life. One of these drugs is Neudexta, which treats Pseudobulbar Affect (PBA) and provides overall relief for bulbar symptoms including difficulty with speech, facial muscle control, chewing, and swallowing.

New articles about the benefits of this drug continue to appear, yet ALS Worldwide has been endorsing generic Neudexta for ten years! In 2007, we pioneered its use as a generic compounded formula, as part of our vision to bring helpful, safe treatments to the ALS community well in advance of the extended clinical trials, which tend to re-prove already known benefits for which a drug is frequently prescribed. An example of such an article can be found by visiting https://alsadotorg.wordpress.com/2017/02/10/nuedexta-trial-demonstrates-promising-results-impacting-bulbar-function-in-als-patients.

ALS Worldwide continues to embrace, endorse, and develop uses for Neudexta, as is the case for multiple drugs that provide excellent symptomatic relief for people fighting ALS. To learn more about Neudexta as well as PBA, please visit http://alsworldwide.org/research-and-trials/article/nuedexta-improving-quality-of-life-for-als-mnd-patients.